Article metrics
PDFRegular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
30 NLR (neutrophil lymphocyte ratio) and PLR (platelet lymphocyte ratio) changes as a predictor of eventual treatment failure and death on nivolumab therapy in renal cell carcinoma
